Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.
Location: United Kingdom, England, Cambridge
Member count: 1-10
Founded date: 2016
Investors 1
| Date | Name | Website |
| 18.05.2023 | Cambridge Inno... | cic.vc |
Mentions in press and media 11
| Date | Title | Description | Source |
| 21.02.2022 | Long-Term ... | Long-Term clinical outcome study of CounterCOVID patients published Lower mortality rate, better cl... | cic.vc/new... |
| 22.06.2021 | Exvastat: ... | Exvastat: The remarkable potential of re-profiled drugs Recently we learned that the use of the med... | cic.vc/new... |
| 21.06.2021 | CounterCOV... | CounterCOVID study shows imatinib significantly reduces mortality by 49% in patients with COVID-19 R... | cic.vc/new... |
| 12.03.2021 | 5 top star... | 5 top startups developing drugs for respiratory diseases Article by Start Us Insights Staying ahea... | cic.vc/new... |
| 27.01.2021 | A year in ... | Cambridge has always been at the forefront of innovation. As the leading venture capital investor in... | cic.vc/new... |
| 22.06.2020 | Annual res... | Expansion to 30 portfolio companies and 46% increase in net asset value, reinforcing CIC’s position ... | cic.vc/new... |
| 02.06.2020 | Exvastat E... | Reformulating Cancer Blockbuster For ARDS by Kevin Grogan | Scrip The UK firm has tapped into EU f... | cic.vc/new... |
| 18.05.2020 | Exvastat recei... | Exvastat receives grant to fund clinical study of existing drug in COVID-19 treatment 18-05-2020 E... | cambridgenetwo... |
| 18.05.2020 | Exvastat recei... | Exvastat (Ireland) Ltd, a privately held biopharmaceutical company backed by Cambridge Innovation Ca... | cambridgenetwo... |
| 15.05.2020 | Exvastat r... | Exvastat receives prestigious Innovative Medicines Initiative grant to fund clinical study of imatin... | cic.vc/new... |
Show more